Johnson & Johnson's Covid-19 vaccine protected monkey in single shot
A leading
candidate of Covid-19 vaccine developed by global healthcare
company Johnson & Johnson raised neutralising antibodies and robustly
protected monkeys against SARS-CoV-2, the virus that causes Covid-19.
"This
vaccine led to robust protection against SARS-CoV-2 in rhesus macaques and is
now being evaluated in humans," said study researcher Dan H. Barouch from
Beth Israel Deaconess Medical Center (BIDMC) in the US.
The
vaccine uses a common cold virus, called adenovirus serotype 26 (Ad26), to
deliver the SARS-CoV-2 spike protein into host cells, where it stimulates the
body to raise immune responses against the coronavirus.
Barouch
has been working on the development of a Covid-19 vaccine since January when
Chinese scientists released the SARS-CoV-2 genome. Read More
Comments
Post a Comment